Skip to main content

Press releases | September 9, 2025

Fried Frank acted as counsel to Merck & Co., Inc., as issuer, in its $6 billion, six-tranche registered public offering of US dollar-denominated senior notes. Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. 

The Fried Frank team was led by corporate partners Daniel J. Bursky and Andrew B. Barkan.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.